News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14,907 Results
Type
Article (830)
Company Profile (6)
Press Release (14071)
Section
Business (4043)
Career Advice (17)
Deals (669)
Drug Delivery (2)
Drug Development (4089)
Employer Resources (4)
FDA (176)
Job Trends (232)
News (8254)
Policy (380)
Tag
2024 Biotech Beach Digital (1)
Academia (92)
Adcomms (1)
Allergies (1)
Alliances (1129)
ALS (4)
Alzheimer's disease (52)
Antibody-drug conjugate (ADC) (5)
Approvals (175)
Artificial intelligence (3)
Bankruptcy (5)
Best Places to Work (214)
Biotechnology (6)
Bladder cancer (5)
Brain cancer (3)
Breast cancer (10)
Cancer (140)
Career advice (15)
CAR-T (4)
Cell therapy (19)
Clinical research (3109)
Collaboration (25)
COVID-19 (85)
C-suite (10)
Data (81)
Diabetes (3)
Diagnostics (33)
Diversity, equity & inclusion (2)
Drug discovery (2)
Drug pricing (2)
Earnings (1425)
Employer resources (4)
Events (3182)
Executive appointments (20)
FDA (199)
Frontotemporal dementia (1)
Funding (27)
Gene editing (2)
Gene therapy (3)
GLP-1 (12)
Government (33)
Healthcare (591)
Immunology and inflammation (11)
Indications (1)
Infectious disease (88)
Inflammatory bowel disease (9)
Influenza (1)
Intellectual property (5)
Interviews (3)
IPO (424)
IRA (2)
Job creations (19)
Job search strategy (13)
Layoffs (8)
Legal (42)
Liver cancer (6)
Lung cancer (20)
Lymphoma (13)
Management (1)
Manufacturing (3)
MASH (1)
Medical device (129)
Medtech (129)
Mergers & acquisitions (261)
Metabolic disorders (7)
Multiple sclerosis (10)
Neurodegenerative disease (4)
Neuroscience (72)
NextGen: Class of 2025 (164)
Non-profit (39)
Northern California (61)
Obesity (3)
Opinion (4)
Ovarian cancer (2)
Pain (1)
Pancreatic cancer (6)
Parkinson's disease (2)
Patents (10)
Patient recruitment (2)
Peanut (1)
People (1317)
Phase I (1478)
Phase II (1612)
Phase III (569)
Pipeline (45)
Policy (2)
Postmarket research (18)
Preclinical (653)
Prostate cancer (7)
Rare diseases (5)
Real estate (37)
Recruiting (1)
Regulatory (349)
Research institute (87)
Resumes & cover letters (3)
Series A (4)
Series B (3)
Sickle cell disease (1)
Southern California (119)
Startups (98)
United States (645)
Vaccines (23)
Weight loss (1)
Date
Last 7 days (23)
Last 30 days (81)
Last 365 days (1217)
2025 (180)
2024 (1265)
2023 (1667)
2022 (1965)
2021 (1957)
2020 (1578)
2019 (952)
2018 (722)
2017 (766)
2016 (676)
2015 (753)
2014 (461)
2013 (278)
2012 (211)
2011 (227)
2010 (183)
Location
Africa (8)
Alabama (2)
Arizona (1)
Asia (745)
Australia (351)
California (218)
Canada (90)
China (6)
Colorado (14)
Connecticut (5)
Delaware (1)
Europe (2580)
Florida (42)
Georgia (1)
Idaho (3)
Illinois (16)
Kansas (1)
Maine (1)
Maryland (13)
Massachusetts (95)
Michigan (1)
Minnesota (1)
Missouri (2)
Montana (8)
Nevada (1)
New Jersey (40)
New York (79)
North Carolina (14)
Northern California (61)
Ohio (4)
Oregon (1)
Pennsylvania (35)
Rhode Island (2)
South America (7)
Southern California (119)
Texas (13)
Utah (3)
Virginia (6)
Washington State (39)
14,907 Results for "innate immunotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
February 27, 2025
·
4 min read
Press Releases
GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit
March 5, 2025
·
3 min read
Press Releases
OSE Immunotherapeutics Hosts KOL Webinar Post-ECCO on Lusvertikimab and the Future of IBD
March 7, 2025
·
3 min read
Press Releases
Innate Pharma Announces Transformative Strategy to Accelerate Growth
January 10, 2025
·
6 min read
Press Releases
NOK Therapeutics, Inc. to Attend 10th Annual Innate Killer Summit in San Diego
February 26, 2025
·
1 min read
Press Releases
Centauri Therapeutics Selects First Clinical Candidate, for Immunotherapeutic Treatment of Gram-negative Bacterial Infections
March 4, 2025
·
2 min read
Press Releases
Lifordi Immunotherapeutics Appoints Matthew W. McClure, M.D., as Chief Medical Officer
January 9, 2025
·
2 min read
Press Releases
Paradox Immunotherapeutics Appoints Sandy Zweifach as Executive Chairman
January 7, 2025
·
3 min read
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
Innate Pharma SA announced that four abstracts with Innate’s drug candidates have been accepted for the European Association of Hematology 2024 Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 15, 2024
·
6 min read
Press Releases
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
February 27, 2025
·
23 min read
1 of 1,491
Next
